A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis

We evaluated the efficacy, pharmacokinetics, and safety of adalimumab in Japanese patients with active ankylosing spondylitis (AS) who had an inadequate response to, or who were intolerant of, treatment with ≥1 nonsteroidal anti-inflammatory drugs (NSAIDs). This phase 3, multicenter, open-label tria...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kobayashi, Shigeto, Harigai, Masayoshi, Mozaffarian, Neelufar, Pangan, Aileen L., Sharma, Shringi, Brown, L. Steven, Miyasaka, Nobuyuki
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Japan 2011
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3416976/
https://ncbi.nlm.nih.gov/pubmed/22205117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10165-011-0557-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge